SGM SHADE MESH
7Pages

Safety Data Sheet for SGM Shade Mesh Section 1: Identification of the Substance/Mixture and of the Company/Undertaking 1.1 Product identifier: Product Name • SHEERFILL® SGM Shade Mesh 1.2 Relevant identified uses of the substance or mixture and uses advised against Relevant identified use(s) • Architectural products 1.3 Details of the supplier of the safety data sheet Manufacturer • Saint-Gobain Performance Plastics 701 Daniel Webster Highway Merrimack, NH 03054 United States Telephone (General) • 603-424-9000 1.4 Emergency telephone number Manufacturer • 603-424-9000 Section 2: Hazards Identification EU/EEC According to EU Directive 1272/2008 (CLP)/REACH 1907/2006 [amended by 453/2010] According to EU Directive 67/548/EEC (DSD) or 1999/45/EC (DPD) 2.1 Classification of the substance or mixture CLP • Not classified DSD/DPD • Not classified 2.2 Label elements CLP - Hazard statements DSD/DPD - Risk phases • Not label element(s) required • Not label element(s) required 2.3 Other hazards CLP DSD/DPD • This material is exempt from CLP/REACH obligations as an article as specified in REACH (1907/2006) and related ECHA guidance. • Under European Directive 1999/45/EC these product(s) are exempt and considered manufactured article(s) under stated normal conditions of use. United States (US) According to OSHA 29 CFR 1910.1200 HCS 2.1 Classification of the substance or mixture OSHA HCS 2012 • Not classified 2.2 Label elements OSHA HCS 2012 • No label element(s) required ©2018 Saint-Gobain Performance Plastics Corporation Valid 01/2018 • Supersedes all pre

2.3 Other hazards OSHA HCS 2012 • Under United States regulations (29 CFR 1910.1200(c) - Hazard Communication Standard), the product(s) listed above are exempt as article(s) under stated normal conditions of use. Canada According to WHMIS 2.1 Classification of the substance or mixture WHMIS • Not classified 2.2 Label elements WHMIS • No label element(s) required 2.3 Other hazards OSHA HCS 2012 • Under Canadian regulations (Workplace Hazardous Materials Information System (WHMIS): Hazardous Products Act (HPA), Section 11(1)), these product(s) are exempt & considered manufactured article(s)...

4.3 Indication of any immediate medical attention and special treatment needed Notes to physician • All treatments should be based on observed signs and symptoms of distress in the patient. Consideration should be given to the possibility that overexposure to materials other than this product may have occurred. Section 5: Firefighting Measures 5.1 Extinguishing media Suitable Extinguishing Media Unsuitable Extinguishing Media • Material is non-combustible. In case of fire, use media as appropriate for surrounding fire. • No data available 5.2 Special hazards arising from the substance or...

• Refer to Section 1.2: Relevant identified uses Section 8: Exposure Controls/Personal Protection 8.1 Control parameters Exposure Limits/Guidelines • This is a solid product in which all components are encapsulated presenting no volatile, dust, or exposure hazards. 8.2 Exposure controls Engineering Measures/ • All components are encapsulated in solid final product. Controls No exposure limits apply. Personal Protective Equipment Respiratory • Under normal conditions of use, respiratory protection is not required. Eye/Face • Under normal conditions of use, eye protection is not required....

• No additional physical and chemical parameters noted. Section 10: Stability and Reactivity 10.1 Reactivity • No dangerous reaction known under conditions of normal use. • Stable under normal temperatures and pressures 10.3 Possibility of hazardous reactions • Hazardous polymerization will not occur. 10.4 Conditions to avoid 10.5 Incompatible materials • No data available. 10.6 Hazardous decomposition products • No data available. Section 11: Toxicological Information 11.1 Information on toxicological effects GHS Properties Acute toxicity EU/CLP • Not relevant OSHA HCS 2012 • Not relevant...

Potential Health Effects Inhalation Acute (Immediate) Chronic (Delayed) • Under normal conditions of use, no health effects are expected. • Under normal conditions of use, no health effects are expected. Skin Acute (Immediate) Chronic (Delayed) • Under normal conditions of use, no health effects are expected. • Under normal conditions of use, no health effects are expected. Eye Acute (Immediate) Chronic (Delayed) • Under normal conditions of use, no health effects are expected. • Under normal conditions of use, no health effects are expected. Ingestion Acute (Immediate) Chronic (Delayed) •...

Section 14: Transport Information 14.1 UN number 14.2 UN proper shipping name 14.3 Transport hazard class(es) 14.6 Special precautions for user • None known. 14.7 Transport in bulk according to Annex II of MARPOL 73/78 and the IBC Code • Not relevant. Section 15: Regulatory Information 15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture SARA Hazard Classifications• None 15.2 Chemical Safety Assessment • Chemical safety assessment is not required. Section 16: Other Information Last Revision Date: Preparation Date: Last Revision Date: •...